Sofinnova Venture Partners IX L.P. 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-19 11:58 am Purchase | 2020-08-11 | 13D | Checkmate Pharmaceuticals, Inc. CMPI | Sofinnova Venture Partners IX L.P. | 3,606,707 16.800% | 3,606,707 (New Position) | Filing |